Back to Search
Kalliga
by Aurobindo Pharma LimitedContraceptionCOCP
Actively PrescribedGeneric

Estrogen

Ethinyl Estradiol

0.03Mg

Progestin

Desogestrel

0.15Mg

Regimen Protocol

Monophasic 28 day

Androgenicity

Low/Reduced Androgenic

Approval Date

5/17/2017

Additives
None
Inactive Ingredients
anhydrous lactoseFD&C Blue No.2 Aluminum Lakecroscarmellose sodiumferric oxide yellowmagnesium stearatemicrocrystalline cellulosepovidone

Contains common allergens

Active Alternative Brands
Alternative brands with the same formulation that are actively prescribed

Teva Pharmaceuticals

Apri

Avion Pharmaceuticals Llc

Averi
Averi

Afaxys Pharma, LLC

Cyred Eq

Mayne Pharma Inc.

Desogestrel And Ethinyl Estradiol

Naari Pte Ltd

Desogestrel And Ethinyl Estradiol

Watson Laboratories Inc

Desogestrel And Ethinyl Estradiol

Novast Laboratories Ltd

Desogestrel And Ethinyl Estradiol

Lupin Pharmaceuticals, Inc.

Enskyce

Xiromed, LLC.

Isibloom

Watson Pharmaceuticals (now part of Teva Pharmaceuticals)

Reclipsen

Unknown

Regulon

Have clinical questions about Kalliga?

Get evidence-based, cited answers from our AI co-pilot for hormone health.

Try Dama Assist

© 2026 Dama Health. All rights reserved.

This tool is intended for use by licensed healthcare professionals. It provides reference information on FDA-approved contraception and hormone therapy products. Results should not be used as a substitute for clinical judgment. Data is sourced from the FDA Orange Book and other FDA-sourced resources and may contain errors or omissions.

Last updated: July 2025 | Powered by Dama Health | Terms of Use | Privacy Policy